Back to Results
First PageMeta Content
Tort law / Drug Price Competition and Patent Term Restoration Act / Generic drug / Tort / Food and Drug Administration / Biosimilar / Abbreviated New Drug Application / Product liability / Pharmaceutical industry / Pharmaceutical sciences / Pharmacology / Clinical research


EXPANDING THE DOCTRINE OF INNOVATOR LIABILITY: USING TORT LIABILITY TO CREATE A VIABLE FOLLOW-ON BIOLOGIC REGIME Prachi V. Mehta*
Add to Reading List

Document Date: 2015-02-08 13:39:12


Open Document

File Size: 487,72 KB

Share Result on Facebook

Company

Label Independence After PLIVA Inc. / Tort Law / University of Illinois Journal / Mutual Pharmaceutical Co. / Hatch-Waxman Act / Mutual Pharmaceuticals / PLIVA Inc. / Innovator Liability After PLIVA Inc. / /

Country

United States / /

Currency

USD / /

Event

FDA Phase / /

Facility

University of Illinois College of Law / University of Illinois Journal / University of California / /

IndustryTerm

pharmaceutical landscape / law duty / chemical and biologic drugs / drug manufacturer / pharmaceutical regulatory framework / manufacturing processes / brand-name product / desirable services / generic drug manufacturer / pharmaceuticals / prospective generic drug manufacturer / biopharmaceutical products / simpler and less subtle technology / manufacturing / healthcare providers / chemical brand-name / larger systems / biotechnology / chemical context / healthcare consumers / healthcare / chemical drugs / generic chemical drugs / chemical drug / federal law / brand-name chemical drugs / tailored solution / chemical composition / costly manufacturing processes / recombinant technology / law can / brand-name chemical drug / /

MedicalCondition

toxic epidermal necrolysis / injury / shoulder pain / Stevens-Johnson Syndrome / disease / medical coma / injuries / /

MedicalTreatment

eye surgeries / /

Movie

Mom and Dad / /

Organization

Supreme Court / United States Court of Appeals / United States District Court for the District of New Hampshire / US Federal Reserve / FDA / New Hampshire District Court / United States Supreme Court / Food and Drug Administration / YALE / Congress / University of Illinois / University of California / Los Angeles / /

Person

MASON L. REV / Dennis Gregory / Jun Wang / Beatrice Skye Resendes / Benjamin C. Zipursky / John C.P. Goldberg / Prutha / Courtney A. Markey / Philip DeShong / Jeremy Tyrrell / Melissa Wasserman / Samantha Koopman / Gregory J. Feeney / Erica Pascal / Susan Randall / Jessica S. Mazer / Caitlyn McCutcheon / Danielle L. Steele / Ernest J. Weinrib / Corbin Freres / John Carroll / Doug Hornig / Lisa Barons / Erik Mogalian / Lesley Wexler / T. JEFFERSON L. REV / Stacey B. Lee / Eric Posner / Chung Chow / Marie Boyd / Richard L. Abel / Ivan Taylor / Nathan Taylor / Arsh / Jay Kesan / DAN B. DOBBS / Gary T. Schwartz / William Lloyd Prosser / Karen Bartlett / J. Dominic Campodonico / CASEY RES / William H. Shrank / Don Jacob / Janet Woodcock / /

Position

ADVISOR / physician / Professor / actor / pharmacist / /

Product

Sulindac / Clinoril / amoxicillin / modern generic drug / /

ProvinceOrState

Indiana / District of Columbia / California / Illinois / New Hampshire / /

PublishedMedium

the University of Illinois Journal / /

Technology

simpler and less subtle technology / recombinant DNA technology / biotechnology / pdf / /

URL

http /

SocialTag